MedPath

NOVO-NAPROX TAB 125MG

NOVO-NAPROX TAB 125MG

Discontinued
DIN Number

00565369

Drug Class

Human

Market Date

Dec 31, 1982

Company
HC

novopharm limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00565369
AIG Number0109634002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AE02 NAPROXEN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

NAPROXENActive
Strength: 125 MG
Monograph: NAPROXEN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.